Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease increased » degree increased (Expand Search), disease increases (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search), largest decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease increased » degree increased (Expand Search), disease increases (Expand Search)
changes decrease » larger decrease (Expand Search), change increases (Expand Search), largest decrease (Expand Search)
-
141
-
142
Average purchase costs of 3GCs and all oral antimicrobials per 100 patient-days from Phases 1–4.
Published 2023Subjects: -
143
-
144
-
145
-
146
-
147
-
148
Trends in the days of cefalexin therapy per 100 patients, by month, during Phases 1 to 4.
Published 2023Subjects: -
149
Trends in the days of quinolone therapy per 100 patients, by month, during Phases 1 to 4.
Published 2023Subjects: -
150
-
151
Trends in the days of macrolides therapy per 100 patients, by month, during Phases 1 to 4.
Published 2023Subjects: -
152
-
153
Change in health utilization measures by group and difference in magnitude of change between groups.
Published 2022Subjects: -
154
-
155
-
156
-
157
-
158
-
159
-
160